+关注
赚钱结婚
暂无个人介绍
IP属地:广东
11
关注
6
粉丝
1
主题
0
勋章
主贴
热门
赚钱结婚
2022-09-01
期待公司的新的增长点
众巢医学宣布新战略延伸,专注于肿瘤及其他重大疾病管理
赚钱结婚
2022-03-16
$众巢医学(ZCMD)$
跌也不怕,涨也不怕,最怕你在今天这个行情下一动不动,交易量去哪里了啊。
赚钱结婚
2021-07-28
$众巢医学(ZCMD)$
全世界都在涨,就你稳如磐石,一动不动[流泪] [流泪] [流泪]
赚钱结婚
2021-06-29
$众巢医学(ZCMD)$
经过近期的观察,底部已经明显,1.63美金左右,而且算是一个坚如磐石的底。目前上升通道已经开启,上涨无明显阻力位,但上涨动力稍显不足。需要企业持续的利好消息,稳定的业绩新高,以及业务板块的拓展。好公司,需要不断的坚守。[微笑] [微笑] [微笑]
赚钱结婚
2020-08-04
$众巢医学(ZCMD)$
换手率百分之130,而且放量集中在4到5美金之间,从4到2.7都是缩量下跌,大概率是这种可能,主力拉高出货,再砸下来获割肉筹码,可以肯定地是,上半年两点多美金的朋友今天都获利出局了,新的流通盘平均成本我预计在3.5到4美金之间,所以,现在的阴跌我觉得是在洗盘,洗盘完接着拉
赚钱结婚
2020-05-15
$众巢医学(ZCMD)$
股价下行至此,市盈率十倍左右,无论是教育行业或是医疗行业,股价早已背离公司价值,年报实实在在的亮眼业绩并没有得到市场的认可,不管什么原因,市场不认可,缺少大机构,或是恶意做空,不管怎样,坚持价值投资,只是时间的问题,退市绝不可能,目前的股价已经低于公司新三板期间定增估值,属于严重低估,目前流动盘较小,人均成本外3.5以上,想不通下跌的的原因,但其实仍坚信会上来的,但需要时间,建议仓位少的,坚持不了的,可以考虑割肉出局,以其他途径弥补亏损,仓位多的或者愿意坚持的,仍可考虑坚守,是金子总会发光,即便不是金子,是块石头,丢进水里也会溅起水花,不会一直沉默下去,相信公司,等待反弹。
赚钱结婚
2020-05-08
$众巢医学(ZCMD)$
期待的年报终于来了,净利润400美金,同比33%增速,符合预期,目前市值5120美金,市盈率仅12.8,严重低估啊,期待今晚的爆发。
赚钱结婚
2020-04-15
$慧择控股(HUIZ)$
五块左右应该是底部了,这个时候还砸盘的,真是家里有矿啊
赚钱结婚
2020-03-23
$众巢医学(ZCMD)$
面对肺炎疫情的恐慌情绪,今天,众巢医学首度发声。早在疫情蔓延初期,众巢的团队已经开始紧急线上办公,为强生、赛诺菲、勃林格殷格翰等世界头部药企制作了60多个肺炎相关课程,公司2020年上半年的业绩将很亮眼。我们坚信这次疫情有可能成为中国继续医学教育行业的一个分水岭,该行业正式从其行业生命周期的起步阶段迈入增长阶段,同时,也是线上医学教育发展的重大契机,这对众巢医学未来的业务发展都是利好。
赚钱结婚
2020-03-10
$众巢医学(ZCMD)$
空头真恶心,2美金抄个底,有本事砸到1美金,坐等一季度报,老子就是不相信,有利润的企业会不反弹。
赚钱结婚
2020-03-05
$众巢医学(ZCMD)$
待投机者抛完了,上升通道就打开了。
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3539817181119812","uuid":"3539817181119812","gmtCreate":1576723159472,"gmtModify":1576723159472,"name":"赚钱结婚","pinyin":"zqjhzhuanqianjiehun","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":11,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.28","exceedPercentage":"93.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":669957226,"gmtCreate":1662046421766,"gmtModify":1662046422801,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"期待公司的新的增长点","listText":"期待公司的新的增长点","text":"期待公司的新的增长点","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/669957226","repostId":"2264291363","repostType":2,"repost":{"id":"2264291363","kind":"news","pubTimestamp":1662031800,"share":"https://www.laohu8.com/m/news/2264291363?lang=&edition=full","pubTime":"2022-09-01 19:30","market":"us","language":"zh","title":"众巢医学宣布新战略延伸,专注于肿瘤及其他重大疾病管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2264291363","media":"美通社","summary":"我们致力于推动医疗和患者服务的数字化创新,并逐步将我们的商业模式向肿瘤和其他重大疾病管理服务 的\"医疗-医药-患者\"延伸。前瞻性声明包括关于计划,目标,目的,战略,未来事件,预期业绩,假设以及其他任何非已经发生的事实性的表述。","content":"<html><body><p><span>上海</span><span>2022年9月1日</span> /美通社/ -- <a href=\"https://laohu8.com/S/ZCMD\">众巢医学</a>(NASDAQ交易代码:ZCMD)(简称\"众巢医学\"或\"公司\"),一家为医护工作者提供在线医疗保健信息及教育培训平台和患者管理服务的互联网科技公司,今天宣布其新增加的肿瘤及其他重大疾病管理业务板块,是其将商业模式从\"医-药\"向\"医-药-患\"拓展的发展战略的一部分。凭借在医学教育和创新方面积累的经验,以及在医学专业人士和制药方面的广泛资源,众巢医学有能力成为为重大疾病患者提供疾病管理服务的平台。</p> <p>公司已实施多项战略举措,向\"医-药-患\"新模式转型。2021年,众巢医学旗下上海众芯医疗科技有限公司(\"众芯健康\"),启动患者管理业务板块,入局肿瘤和罕见病领域的专业化患者管理。这是其转型的重要第一步,而该战略延伸是由在中国\"以患者为中心\"的医疗需求增加所推动的。自2021年以来,管理层一直在密切观察和监测这种服务模式,即为每个患者提供量身定制的医疗服务和疾病管理,并允许患者积极主动地参与健康管理和疾病治疗。根据公司在2017年11月至2021年9月期间收集的数据,与未使用管理系统的患者相比,众巢医学自主研发的患者管理系统成功使肝癌患者治疗持续时间(DOT)提升40.4%,为药物的最大效率、成功治疗和延长患者生存期做出了贡献。公司计划通过众芯健康继续发展患者管理服务。</p> <p>截至目前,众芯健康已为接受治疗的肿瘤患者提供全方位的疾病教育及管理服务,通过药品援助、疾病随访、用药管理、癌症科普等服务,帮助肿瘤患者减轻治疗经济负担,完成治疗进程,从而获得最佳治疗效果,提高生活质量。截至目前,已有数十万肿瘤患者通过众芯健康自主搭建的小程序或微信网络服务平台,将患者与众芯健康的热线中心、服务专员系统连接,并获得疾病管理支持。</p> <p>众巢医学董事长兼首席执行官杨伟光先生评论道:\"作为中国医学教育的数字平台,众巢医学持续为患者及医护人员提供科学、可靠的医疗信息。我们致力于推动医疗和患者服务的数字化创新,并逐步将我们的商业模式向肿瘤和其他重大疾病管理服务 的\"医疗-医药-患者\"延伸。我们相信,我们的新商业模式将使个人健康得到更有效的提升,改善患者体验,优化资源配置,并在未来为我们的股东带来更多价值。\"</p> <p><b>关于众巢医学</b></p> <p>众巢医学成立于2012年,办公室位于上海和北京,是一家平台化互联网科技公司。众巢医学通过其旗下\"医学慕课\"()平台为医护工作者提供在线专业医学培训和教育服务,通过其旗下\"众芯医疗\"提供肿瘤和罕见疾病专业领域的患者管理服务,以及运营\"阳光健康学堂\"平台为大众提供医疗保健信息。更多信息请访问公司投资者关系网站: 。</p> <p><b>前瞻性声明</b></p> <p><i>本新闻稿中有关公司的未来预期、计划和前景展望的陈述构成</i><i>Private Securities Litigation Reform Act of 1995所界定的前瞻性声明。前瞻性声明包括关于计划,目标,目的,战略,未来事件,预期业绩,假设以及其他任何非已经发生的事实性的表述。任何文字表述中涉及\"可能\",\"将要\",\"想要\", \"应该\", \"相信\", \"预期\", \"期待\", \"预估\", \"估计\"或类似的非事实性的文字都应视为前瞻性声明。受各种因素的影响,实际结果可能与历史结果或这些前瞻性声明中表述的内容有重大出入。这些因素包括但不限于公司的战略目标,公司的未来规划,公司产品或服务的市场需求和用户接受度,技术更新,经济走势、中国医疗保健信息,教育及培训服务市场的增长,企业的名声和品牌,行业竞争和竞价的影响,相关政策法规,中国宏观经济状况的起伏,公司服务的国际市场情况,招股说明书中披露的相关风险和有关假设,括其对我们业务和运营的影响。鉴于以上原因及其它相关原因,我们建议投资者切勿盲目信赖该等前瞻性表述,并且,我们敦促投资者登陆SEC网站查阅公司相关文件以获取其他可能影响公司未来运营结果的因素。公司没有义务在这些文件申报以后由于特定事件或原因所引起的这些前瞻性声明的改变做公开修正。</i></p> <p><b>详情请联系:</b>公司联系人:徐珮,首席财务官电邮: 电话: +86 21-3220-5987</p> <p>投资者关系联系人:<span>Sherry Zheng</span>万千集团电邮: 电话: +1 718-213-7386</p> </body></html>","source":"prnasia","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>众巢医学宣布新战略延伸,专注于肿瘤及其他重大疾病管理</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n众巢医学宣布新战略延伸,专注于肿瘤及其他重大疾病管理\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 19:30 北京时间 <a href=https://wwwold.prnasia.com/story/archive/3860602_ZH60602_1><strong>美通社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>上海2022年9月1日 /美通社/ -- 众巢医学(NASDAQ交易代码:ZCMD)(简称\"众巢医学\"或\"公司\"),一家为医护工作者提供在线医疗保健信息及教育培训平台和患者管理服务的互联网科技公司,今天宣布其新增加的肿瘤及其他重大疾病管理业务板块,是其将商业模式从\"医-药\"向\"医-药-患\"拓展的发展战略的一部分。凭借在医学教育和创新方面积累的经验,以及在医学专业人士和制药方面的广泛资源,众巢医学有...</p>\n\n<a href=\"https://wwwold.prnasia.com/story/archive/3860602_ZH60602_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZCMD":"众巢医学","BK4204":"教育服务"},"source_url":"https://wwwold.prnasia.com/story/archive/3860602_ZH60602_1","is_english":false,"share_image_url":"https://static.laohu8.com/7d5258e5fa9d58069a293859983c0a71","article_id":"2264291363","content_text":"上海2022年9月1日 /美通社/ -- 众巢医学(NASDAQ交易代码:ZCMD)(简称\"众巢医学\"或\"公司\"),一家为医护工作者提供在线医疗保健信息及教育培训平台和患者管理服务的互联网科技公司,今天宣布其新增加的肿瘤及其他重大疾病管理业务板块,是其将商业模式从\"医-药\"向\"医-药-患\"拓展的发展战略的一部分。凭借在医学教育和创新方面积累的经验,以及在医学专业人士和制药方面的广泛资源,众巢医学有能力成为为重大疾病患者提供疾病管理服务的平台。 公司已实施多项战略举措,向\"医-药-患\"新模式转型。2021年,众巢医学旗下上海众芯医疗科技有限公司(\"众芯健康\"),启动患者管理业务板块,入局肿瘤和罕见病领域的专业化患者管理。这是其转型的重要第一步,而该战略延伸是由在中国\"以患者为中心\"的医疗需求增加所推动的。自2021年以来,管理层一直在密切观察和监测这种服务模式,即为每个患者提供量身定制的医疗服务和疾病管理,并允许患者积极主动地参与健康管理和疾病治疗。根据公司在2017年11月至2021年9月期间收集的数据,与未使用管理系统的患者相比,众巢医学自主研发的患者管理系统成功使肝癌患者治疗持续时间(DOT)提升40.4%,为药物的最大效率、成功治疗和延长患者生存期做出了贡献。公司计划通过众芯健康继续发展患者管理服务。 截至目前,众芯健康已为接受治疗的肿瘤患者提供全方位的疾病教育及管理服务,通过药品援助、疾病随访、用药管理、癌症科普等服务,帮助肿瘤患者减轻治疗经济负担,完成治疗进程,从而获得最佳治疗效果,提高生活质量。截至目前,已有数十万肿瘤患者通过众芯健康自主搭建的小程序或微信网络服务平台,将患者与众芯健康的热线中心、服务专员系统连接,并获得疾病管理支持。 众巢医学董事长兼首席执行官杨伟光先生评论道:\"作为中国医学教育的数字平台,众巢医学持续为患者及医护人员提供科学、可靠的医疗信息。我们致力于推动医疗和患者服务的数字化创新,并逐步将我们的商业模式向肿瘤和其他重大疾病管理服务 的\"医疗-医药-患者\"延伸。我们相信,我们的新商业模式将使个人健康得到更有效的提升,改善患者体验,优化资源配置,并在未来为我们的股东带来更多价值。\" 关于众巢医学 众巢医学成立于2012年,办公室位于上海和北京,是一家平台化互联网科技公司。众巢医学通过其旗下\"医学慕课\"()平台为医护工作者提供在线专业医学培训和教育服务,通过其旗下\"众芯医疗\"提供肿瘤和罕见疾病专业领域的患者管理服务,以及运营\"阳光健康学堂\"平台为大众提供医疗保健信息。更多信息请访问公司投资者关系网站: 。 前瞻性声明 本新闻稿中有关公司的未来预期、计划和前景展望的陈述构成Private Securities Litigation Reform Act of 1995所界定的前瞻性声明。前瞻性声明包括关于计划,目标,目的,战略,未来事件,预期业绩,假设以及其他任何非已经发生的事实性的表述。任何文字表述中涉及\"可能\",\"将要\",\"想要\", \"应该\", \"相信\", \"预期\", \"期待\", \"预估\", \"估计\"或类似的非事实性的文字都应视为前瞻性声明。受各种因素的影响,实际结果可能与历史结果或这些前瞻性声明中表述的内容有重大出入。这些因素包括但不限于公司的战略目标,公司的未来规划,公司产品或服务的市场需求和用户接受度,技术更新,经济走势、中国医疗保健信息,教育及培训服务市场的增长,企业的名声和品牌,行业竞争和竞价的影响,相关政策法规,中国宏观经济状况的起伏,公司服务的国际市场情况,招股说明书中披露的相关风险和有关假设,括其对我们业务和运营的影响。鉴于以上原因及其它相关原因,我们建议投资者切勿盲目信赖该等前瞻性表述,并且,我们敦促投资者登陆SEC网站查阅公司相关文件以获取其他可能影响公司未来运营结果的因素。公司没有义务在这些文件申报以后由于特定事件或原因所引起的这些前瞻性声明的改变做公开修正。 详情请联系:公司联系人:徐珮,首席财务官电邮: 电话: +86 21-3220-5987 投资者关系联系人:Sherry Zheng万千集团电邮: 电话: +1 718-213-7386","news_type":1},"isVote":1,"tweetType":1,"viewCount":1188,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":634601491,"gmtCreate":1647446227713,"gmtModify":1647446227713,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>跌也不怕,涨也不怕,最怕你在今天这个行情下一动不动,交易量去哪里了啊。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>跌也不怕,涨也不怕,最怕你在今天这个行情下一动不动,交易量去哪里了啊。","text":"$众巢医学(ZCMD)$跌也不怕,涨也不怕,最怕你在今天这个行情下一动不动,交易量去哪里了啊。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/634601491","isVote":1,"tweetType":1,"viewCount":1779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":801180618,"gmtCreate":1627487608534,"gmtModify":1627487608534,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>全世界都在涨,就你稳如磐石,一动不动[流泪] [流泪] [流泪] ","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>全世界都在涨,就你稳如磐石,一动不动[流泪] [流泪] [流泪] ","text":"$众巢医学(ZCMD)$全世界都在涨,就你稳如磐石,一动不动[流泪] [流泪] [流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/801180618","isVote":1,"tweetType":1,"viewCount":1598,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":159889630,"gmtCreate":1624955494120,"gmtModify":1624955494120,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>经过近期的观察,底部已经明显,1.63美金左右,而且算是一个坚如磐石的底。目前上升通道已经开启,上涨无明显阻力位,但上涨动力稍显不足。需要企业持续的利好消息,稳定的业绩新高,以及业务板块的拓展。好公司,需要不断的坚守。[微笑] [微笑] [微笑] ","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>经过近期的观察,底部已经明显,1.63美金左右,而且算是一个坚如磐石的底。目前上升通道已经开启,上涨无明显阻力位,但上涨动力稍显不足。需要企业持续的利好消息,稳定的业绩新高,以及业务板块的拓展。好公司,需要不断的坚守。[微笑] [微笑] [微笑] ","text":"$众巢医学(ZCMD)$经过近期的观察,底部已经明显,1.63美金左右,而且算是一个坚如磐石的底。目前上升通道已经开启,上涨无明显阻力位,但上涨动力稍显不足。需要企业持续的利好消息,稳定的业绩新高,以及业务板块的拓展。好公司,需要不断的坚守。[微笑] [微笑] [微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159889630","isVote":1,"tweetType":1,"viewCount":2872,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":945676840,"gmtCreate":1596554897180,"gmtModify":1704212697547,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>换手率百分之130,而且放量集中在4到5美金之间,从4到2.7都是缩量下跌,大概率是这种可能,主力拉高出货,再砸下来获割肉筹码,可以肯定地是,上半年两点多美金的朋友今天都获利出局了,新的流通盘平均成本我预计在3.5到4美金之间,所以,现在的阴跌我觉得是在洗盘,洗盘完接着拉","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>换手率百分之130,而且放量集中在4到5美金之间,从4到2.7都是缩量下跌,大概率是这种可能,主力拉高出货,再砸下来获割肉筹码,可以肯定地是,上半年两点多美金的朋友今天都获利出局了,新的流通盘平均成本我预计在3.5到4美金之间,所以,现在的阴跌我觉得是在洗盘,洗盘完接着拉","text":"$众巢医学(ZCMD)$换手率百分之130,而且放量集中在4到5美金之间,从4到2.7都是缩量下跌,大概率是这种可能,主力拉高出货,再砸下来获割肉筹码,可以肯定地是,上半年两点多美金的朋友今天都获利出局了,新的流通盘平均成本我预计在3.5到4美金之间,所以,现在的阴跌我觉得是在洗盘,洗盘完接着拉","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/945676840","isVote":1,"tweetType":1,"viewCount":4596,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3550153001684587","authorId":"3550153001684587","name":"DESTINY13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3550153001684587","authorIdStr":"3550153001684587"},"content":"3。23成本还能持有吗。。","text":"3。23成本还能持有吗。。","html":"3。23成本还能持有吗。。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":959082280,"gmtCreate":1589557071040,"gmtModify":1704190329712,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>股价下行至此,市盈率十倍左右,无论是教育行业或是医疗行业,股价早已背离公司价值,年报实实在在的亮眼业绩并没有得到市场的认可,不管什么原因,市场不认可,缺少大机构,或是恶意做空,不管怎样,坚持价值投资,只是时间的问题,退市绝不可能,目前的股价已经低于公司新三板期间定增估值,属于严重低估,目前流动盘较小,人均成本外3.5以上,想不通下跌的的原因,但其实仍坚信会上来的,但需要时间,建议仓位少的,坚持不了的,可以考虑割肉出局,以其他途径弥补亏损,仓位多的或者愿意坚持的,仍可考虑坚守,是金子总会发光,即便不是金子,是块石头,丢进水里也会溅起水花,不会一直沉默下去,相信公司,等待反弹。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>股价下行至此,市盈率十倍左右,无论是教育行业或是医疗行业,股价早已背离公司价值,年报实实在在的亮眼业绩并没有得到市场的认可,不管什么原因,市场不认可,缺少大机构,或是恶意做空,不管怎样,坚持价值投资,只是时间的问题,退市绝不可能,目前的股价已经低于公司新三板期间定增估值,属于严重低估,目前流动盘较小,人均成本外3.5以上,想不通下跌的的原因,但其实仍坚信会上来的,但需要时间,建议仓位少的,坚持不了的,可以考虑割肉出局,以其他途径弥补亏损,仓位多的或者愿意坚持的,仍可考虑坚守,是金子总会发光,即便不是金子,是块石头,丢进水里也会溅起水花,不会一直沉默下去,相信公司,等待反弹。","text":"$众巢医学(ZCMD)$股价下行至此,市盈率十倍左右,无论是教育行业或是医疗行业,股价早已背离公司价值,年报实实在在的亮眼业绩并没有得到市场的认可,不管什么原因,市场不认可,缺少大机构,或是恶意做空,不管怎样,坚持价值投资,只是时间的问题,退市绝不可能,目前的股价已经低于公司新三板期间定增估值,属于严重低估,目前流动盘较小,人均成本外3.5以上,想不通下跌的的原因,但其实仍坚信会上来的,但需要时间,建议仓位少的,坚持不了的,可以考虑割肉出局,以其他途径弥补亏损,仓位多的或者愿意坚持的,仍可考虑坚守,是金子总会发光,即便不是金子,是块石头,丢进水里也会溅起水花,不会一直沉默下去,相信公司,等待反弹。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/959082280","isVote":1,"tweetType":1,"viewCount":4857,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3542338789557299","authorId":"3542338789557299","name":"随机昵称随机","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3542338789557299","authorIdStr":"3542338789557299"},"content":"你买了多少这么有信心","text":"你买了多少这么有信心","html":"你买了多少这么有信心"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":927526754,"gmtCreate":1588940569278,"gmtModify":1704178966456,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>期待的年报终于来了,净利润400美金,同比33%增速,符合预期,目前市值5120美金,市盈率仅12.8,严重低估啊,期待今晚的爆发。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>期待的年报终于来了,净利润400美金,同比33%增速,符合预期,目前市值5120美金,市盈率仅12.8,严重低估啊,期待今晚的爆发。","text":"$众巢医学(ZCMD)$期待的年报终于来了,净利润400美金,同比33%增速,符合预期,目前市值5120美金,市盈率仅12.8,严重低估啊,期待今晚的爆发。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/927526754","isVote":1,"tweetType":1,"viewCount":2511,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":928716341,"gmtCreate":1586881680983,"gmtModify":1704362426113,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HUIZ\">$慧择控股(HUIZ)$</a> 五块左右应该是底部了,这个时候还砸盘的,真是家里有矿啊","listText":"<a href=\"https://laohu8.com/S/HUIZ\">$慧择控股(HUIZ)$</a> 五块左右应该是底部了,这个时候还砸盘的,真是家里有矿啊","text":"$慧择控股(HUIZ)$ 五块左右应该是底部了,这个时候还砸盘的,真是家里有矿啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/928716341","isVote":1,"tweetType":1,"viewCount":1452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":920152166,"gmtCreate":1584965769955,"gmtModify":1704356295082,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 面对肺炎疫情的恐慌情绪,今天,众巢医学首度发声。早在疫情蔓延初期,众巢的团队已经开始紧急线上办公,为强生、赛诺菲、勃林格殷格翰等世界头部药企制作了60多个肺炎相关课程,公司2020年上半年的业绩将很亮眼。我们坚信这次疫情有可能成为中国继续医学教育行业的一个分水岭,该行业正式从其行业生命周期的起步阶段迈入增长阶段,同时,也是线上医学教育发展的重大契机,这对众巢医学未来的业务发展都是利好。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 面对肺炎疫情的恐慌情绪,今天,众巢医学首度发声。早在疫情蔓延初期,众巢的团队已经开始紧急线上办公,为强生、赛诺菲、勃林格殷格翰等世界头部药企制作了60多个肺炎相关课程,公司2020年上半年的业绩将很亮眼。我们坚信这次疫情有可能成为中国继续医学教育行业的一个分水岭,该行业正式从其行业生命周期的起步阶段迈入增长阶段,同时,也是线上医学教育发展的重大契机,这对众巢医学未来的业务发展都是利好。","text":"$众巢医学(ZCMD)$ 面对肺炎疫情的恐慌情绪,今天,众巢医学首度发声。早在疫情蔓延初期,众巢的团队已经开始紧急线上办公,为强生、赛诺菲、勃林格殷格翰等世界头部药企制作了60多个肺炎相关课程,公司2020年上半年的业绩将很亮眼。我们坚信这次疫情有可能成为中国继续医学教育行业的一个分水岭,该行业正式从其行业生命周期的起步阶段迈入增长阶段,同时,也是线上医学教育发展的重大契机,这对众巢医学未来的业务发展都是利好。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/920152166","isVote":1,"tweetType":1,"viewCount":3427,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3544479599150616","authorId":"3544479599150616","name":"西西里董董","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3544479599150616","authorIdStr":"3544479599150616"},"content":"认可这个行业在疫情后会迎来行业生命周期从起步迈入增长阶段,赶走空头,坚定持有[开心]","text":"认可这个行业在疫情后会迎来行业生命周期从起步迈入增长阶段,赶走空头,坚定持有[开心]","html":"认可这个行业在疫情后会迎来行业生命周期从起步迈入增长阶段,赶走空头,坚定持有[开心]"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":988902606,"gmtCreate":1583854944405,"gmtModify":1704351337537,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 空头真恶心,2美金抄个底,有本事砸到1美金,坐等一季度报,老子就是不相信,有利润的企业会不反弹。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 空头真恶心,2美金抄个底,有本事砸到1美金,坐等一季度报,老子就是不相信,有利润的企业会不反弹。","text":"$众巢医学(ZCMD)$ 空头真恶心,2美金抄个底,有本事砸到1美金,坐等一季度报,老子就是不相信,有利润的企业会不反弹。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/988902606","isVote":1,"tweetType":1,"viewCount":2350,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3540112291574766","authorId":"3540112291574766","name":"锦绣龙宫","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3540112291574766","authorIdStr":"3540112291574766"},"content":"那不一定,季报他们照样做空不让股票涨,他们不需要多钱就可以控制这个公司!","text":"那不一定,季报他们照样做空不让股票涨,他们不需要多钱就可以控制这个公司!","html":"那不一定,季报他们照样做空不让股票涨,他们不需要多钱就可以控制这个公司!"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":981000810,"gmtCreate":1583421867930,"gmtModify":1704349815158,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 待投机者抛完了,上升通道就打开了。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 待投机者抛完了,上升通道就打开了。","text":"$众巢医学(ZCMD)$ 待投机者抛完了,上升通道就打开了。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/981000810","isVote":1,"tweetType":1,"viewCount":2381,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":959082280,"gmtCreate":1589557071040,"gmtModify":1704190329712,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>股价下行至此,市盈率十倍左右,无论是教育行业或是医疗行业,股价早已背离公司价值,年报实实在在的亮眼业绩并没有得到市场的认可,不管什么原因,市场不认可,缺少大机构,或是恶意做空,不管怎样,坚持价值投资,只是时间的问题,退市绝不可能,目前的股价已经低于公司新三板期间定增估值,属于严重低估,目前流动盘较小,人均成本外3.5以上,想不通下跌的的原因,但其实仍坚信会上来的,但需要时间,建议仓位少的,坚持不了的,可以考虑割肉出局,以其他途径弥补亏损,仓位多的或者愿意坚持的,仍可考虑坚守,是金子总会发光,即便不是金子,是块石头,丢进水里也会溅起水花,不会一直沉默下去,相信公司,等待反弹。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>股价下行至此,市盈率十倍左右,无论是教育行业或是医疗行业,股价早已背离公司价值,年报实实在在的亮眼业绩并没有得到市场的认可,不管什么原因,市场不认可,缺少大机构,或是恶意做空,不管怎样,坚持价值投资,只是时间的问题,退市绝不可能,目前的股价已经低于公司新三板期间定增估值,属于严重低估,目前流动盘较小,人均成本外3.5以上,想不通下跌的的原因,但其实仍坚信会上来的,但需要时间,建议仓位少的,坚持不了的,可以考虑割肉出局,以其他途径弥补亏损,仓位多的或者愿意坚持的,仍可考虑坚守,是金子总会发光,即便不是金子,是块石头,丢进水里也会溅起水花,不会一直沉默下去,相信公司,等待反弹。","text":"$众巢医学(ZCMD)$股价下行至此,市盈率十倍左右,无论是教育行业或是医疗行业,股价早已背离公司价值,年报实实在在的亮眼业绩并没有得到市场的认可,不管什么原因,市场不认可,缺少大机构,或是恶意做空,不管怎样,坚持价值投资,只是时间的问题,退市绝不可能,目前的股价已经低于公司新三板期间定增估值,属于严重低估,目前流动盘较小,人均成本外3.5以上,想不通下跌的的原因,但其实仍坚信会上来的,但需要时间,建议仓位少的,坚持不了的,可以考虑割肉出局,以其他途径弥补亏损,仓位多的或者愿意坚持的,仍可考虑坚守,是金子总会发光,即便不是金子,是块石头,丢进水里也会溅起水花,不会一直沉默下去,相信公司,等待反弹。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/959082280","isVote":1,"tweetType":1,"viewCount":4857,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3542338789557299","authorId":"3542338789557299","name":"随机昵称随机","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3542338789557299","authorIdStr":"3542338789557299"},"content":"你买了多少这么有信心","text":"你买了多少这么有信心","html":"你买了多少这么有信心"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":927526754,"gmtCreate":1588940569278,"gmtModify":1704178966456,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>期待的年报终于来了,净利润400美金,同比33%增速,符合预期,目前市值5120美金,市盈率仅12.8,严重低估啊,期待今晚的爆发。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>期待的年报终于来了,净利润400美金,同比33%增速,符合预期,目前市值5120美金,市盈率仅12.8,严重低估啊,期待今晚的爆发。","text":"$众巢医学(ZCMD)$期待的年报终于来了,净利润400美金,同比33%增速,符合预期,目前市值5120美金,市盈率仅12.8,严重低估啊,期待今晚的爆发。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/927526754","isVote":1,"tweetType":1,"viewCount":2511,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":981000810,"gmtCreate":1583421867930,"gmtModify":1704349815158,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 待投机者抛完了,上升通道就打开了。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 待投机者抛完了,上升通道就打开了。","text":"$众巢医学(ZCMD)$ 待投机者抛完了,上升通道就打开了。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/981000810","isVote":1,"tweetType":1,"viewCount":2381,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":920152166,"gmtCreate":1584965769955,"gmtModify":1704356295082,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 面对肺炎疫情的恐慌情绪,今天,众巢医学首度发声。早在疫情蔓延初期,众巢的团队已经开始紧急线上办公,为强生、赛诺菲、勃林格殷格翰等世界头部药企制作了60多个肺炎相关课程,公司2020年上半年的业绩将很亮眼。我们坚信这次疫情有可能成为中国继续医学教育行业的一个分水岭,该行业正式从其行业生命周期的起步阶段迈入增长阶段,同时,也是线上医学教育发展的重大契机,这对众巢医学未来的业务发展都是利好。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 面对肺炎疫情的恐慌情绪,今天,众巢医学首度发声。早在疫情蔓延初期,众巢的团队已经开始紧急线上办公,为强生、赛诺菲、勃林格殷格翰等世界头部药企制作了60多个肺炎相关课程,公司2020年上半年的业绩将很亮眼。我们坚信这次疫情有可能成为中国继续医学教育行业的一个分水岭,该行业正式从其行业生命周期的起步阶段迈入增长阶段,同时,也是线上医学教育发展的重大契机,这对众巢医学未来的业务发展都是利好。","text":"$众巢医学(ZCMD)$ 面对肺炎疫情的恐慌情绪,今天,众巢医学首度发声。早在疫情蔓延初期,众巢的团队已经开始紧急线上办公,为强生、赛诺菲、勃林格殷格翰等世界头部药企制作了60多个肺炎相关课程,公司2020年上半年的业绩将很亮眼。我们坚信这次疫情有可能成为中国继续医学教育行业的一个分水岭,该行业正式从其行业生命周期的起步阶段迈入增长阶段,同时,也是线上医学教育发展的重大契机,这对众巢医学未来的业务发展都是利好。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/920152166","isVote":1,"tweetType":1,"viewCount":3427,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3544479599150616","authorId":"3544479599150616","name":"西西里董董","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3544479599150616","authorIdStr":"3544479599150616"},"content":"认可这个行业在疫情后会迎来行业生命周期从起步迈入增长阶段,赶走空头,坚定持有[开心]","text":"认可这个行业在疫情后会迎来行业生命周期从起步迈入增长阶段,赶走空头,坚定持有[开心]","html":"认可这个行业在疫情后会迎来行业生命周期从起步迈入增长阶段,赶走空头,坚定持有[开心]"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":945676840,"gmtCreate":1596554897180,"gmtModify":1704212697547,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>换手率百分之130,而且放量集中在4到5美金之间,从4到2.7都是缩量下跌,大概率是这种可能,主力拉高出货,再砸下来获割肉筹码,可以肯定地是,上半年两点多美金的朋友今天都获利出局了,新的流通盘平均成本我预计在3.5到4美金之间,所以,现在的阴跌我觉得是在洗盘,洗盘完接着拉","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>换手率百分之130,而且放量集中在4到5美金之间,从4到2.7都是缩量下跌,大概率是这种可能,主力拉高出货,再砸下来获割肉筹码,可以肯定地是,上半年两点多美金的朋友今天都获利出局了,新的流通盘平均成本我预计在3.5到4美金之间,所以,现在的阴跌我觉得是在洗盘,洗盘完接着拉","text":"$众巢医学(ZCMD)$换手率百分之130,而且放量集中在4到5美金之间,从4到2.7都是缩量下跌,大概率是这种可能,主力拉高出货,再砸下来获割肉筹码,可以肯定地是,上半年两点多美金的朋友今天都获利出局了,新的流通盘平均成本我预计在3.5到4美金之间,所以,现在的阴跌我觉得是在洗盘,洗盘完接着拉","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/945676840","isVote":1,"tweetType":1,"viewCount":4596,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3550153001684587","authorId":"3550153001684587","name":"DESTINY13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3550153001684587","authorIdStr":"3550153001684587"},"content":"3。23成本还能持有吗。。","text":"3。23成本还能持有吗。。","html":"3。23成本还能持有吗。。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":988902606,"gmtCreate":1583854944405,"gmtModify":1704351337537,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 空头真恶心,2美金抄个底,有本事砸到1美金,坐等一季度报,老子就是不相信,有利润的企业会不反弹。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a> 空头真恶心,2美金抄个底,有本事砸到1美金,坐等一季度报,老子就是不相信,有利润的企业会不反弹。","text":"$众巢医学(ZCMD)$ 空头真恶心,2美金抄个底,有本事砸到1美金,坐等一季度报,老子就是不相信,有利润的企业会不反弹。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/988902606","isVote":1,"tweetType":1,"viewCount":2350,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3540112291574766","authorId":"3540112291574766","name":"锦绣龙宫","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3540112291574766","authorIdStr":"3540112291574766"},"content":"那不一定,季报他们照样做空不让股票涨,他们不需要多钱就可以控制这个公司!","text":"那不一定,季报他们照样做空不让股票涨,他们不需要多钱就可以控制这个公司!","html":"那不一定,季报他们照样做空不让股票涨,他们不需要多钱就可以控制这个公司!"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":801180618,"gmtCreate":1627487608534,"gmtModify":1627487608534,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>全世界都在涨,就你稳如磐石,一动不动[流泪] [流泪] [流泪] ","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>全世界都在涨,就你稳如磐石,一动不动[流泪] [流泪] [流泪] ","text":"$众巢医学(ZCMD)$全世界都在涨,就你稳如磐石,一动不动[流泪] [流泪] [流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/801180618","isVote":1,"tweetType":1,"viewCount":1598,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":159889630,"gmtCreate":1624955494120,"gmtModify":1624955494120,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>经过近期的观察,底部已经明显,1.63美金左右,而且算是一个坚如磐石的底。目前上升通道已经开启,上涨无明显阻力位,但上涨动力稍显不足。需要企业持续的利好消息,稳定的业绩新高,以及业务板块的拓展。好公司,需要不断的坚守。[微笑] [微笑] [微笑] ","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>经过近期的观察,底部已经明显,1.63美金左右,而且算是一个坚如磐石的底。目前上升通道已经开启,上涨无明显阻力位,但上涨动力稍显不足。需要企业持续的利好消息,稳定的业绩新高,以及业务板块的拓展。好公司,需要不断的坚守。[微笑] [微笑] [微笑] ","text":"$众巢医学(ZCMD)$经过近期的观察,底部已经明显,1.63美金左右,而且算是一个坚如磐石的底。目前上升通道已经开启,上涨无明显阻力位,但上涨动力稍显不足。需要企业持续的利好消息,稳定的业绩新高,以及业务板块的拓展。好公司,需要不断的坚守。[微笑] [微笑] [微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159889630","isVote":1,"tweetType":1,"viewCount":2872,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":634601491,"gmtCreate":1647446227713,"gmtModify":1647446227713,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>跌也不怕,涨也不怕,最怕你在今天这个行情下一动不动,交易量去哪里了啊。","listText":"<a href=\"https://laohu8.com/S/ZCMD\">$众巢医学(ZCMD)$</a>跌也不怕,涨也不怕,最怕你在今天这个行情下一动不动,交易量去哪里了啊。","text":"$众巢医学(ZCMD)$跌也不怕,涨也不怕,最怕你在今天这个行情下一动不动,交易量去哪里了啊。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/634601491","isVote":1,"tweetType":1,"viewCount":1779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":669957226,"gmtCreate":1662046421766,"gmtModify":1662046422801,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"期待公司的新的增长点","listText":"期待公司的新的增长点","text":"期待公司的新的增长点","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/669957226","repostId":"2264291363","repostType":2,"isVote":1,"tweetType":1,"viewCount":1188,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":928716341,"gmtCreate":1586881680983,"gmtModify":1704362426113,"author":{"id":"3539817181119812","authorId":"3539817181119812","name":"赚钱结婚","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3539817181119812","authorIdStr":"3539817181119812"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HUIZ\">$慧择控股(HUIZ)$</a> 五块左右应该是底部了,这个时候还砸盘的,真是家里有矿啊","listText":"<a href=\"https://laohu8.com/S/HUIZ\">$慧择控股(HUIZ)$</a> 五块左右应该是底部了,这个时候还砸盘的,真是家里有矿啊","text":"$慧择控股(HUIZ)$ 五块左右应该是底部了,这个时候还砸盘的,真是家里有矿啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/928716341","isVote":1,"tweetType":1,"viewCount":1452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}